missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VSIG4 (aa 20-283) Fc Chimera Protein
Click to view available options
Menge:
50 μg
Packungsgröße:
50 Mikrogramm
Beschreibung
Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human VSIG4 Fc Chimera at 5 μg/mL (100 μL/well) can bind complement component iC3b with an apparent Kd <20 nM.
Spezifikation
Spezifikation
| Zugriffsnummer | Q9Y279 |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Gen-ID (Entrez) | 11326 |
| Molekulargewicht | M.W. (Observed): 60-70 kDa, reducing conditions; M.W. (theoretical): 55.8 kDa (monomer) |
| Name | VSIG4 Fc Chimera |
| Menge | 50 μg |
| Quelle | Mouse myeloma cell line, NS0-derived human VSIG4 protein Human VSIG4 (Arg20-Pro283) (N-terminus) Accession # Q9Y279 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Strukturform | Disulfide-linked homodimer |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction